AU3962500A - Method of producing 3,4-dihydroprolines and 3,4-dehydropiperidines - Google Patents

Method of producing 3,4-dihydroprolines and 3,4-dehydropiperidines

Info

Publication number
AU3962500A
AU3962500A AU39625/00A AU3962500A AU3962500A AU 3962500 A AU3962500 A AU 3962500A AU 39625/00 A AU39625/00 A AU 39625/00A AU 3962500 A AU3962500 A AU 3962500A AU 3962500 A AU3962500 A AU 3962500A
Authority
AU
Australia
Prior art keywords
alkyl
dihydroprolines
dehydropiperidines
producing
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39625/00A
Other languages
English (en)
Inventor
Gunter Helmchen
Uli Kazmaier
Bernd Schafer
Simone Schleich
Helmut Stahr
Volker Wolfart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of AU3962500A publication Critical patent/AU3962500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU39625/00A 1999-03-26 2000-03-17 Method of producing 3,4-dihydroprolines and 3,4-dehydropiperidines Abandoned AU3962500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19913699A DE19913699A1 (de) 1999-03-26 1999-03-26 Verfahren zur Herstellung von 3,4-Dihydroprolinen und 3,4-Dehydropiperidinen
DE19913699 1999-03-26
PCT/EP2000/002377 WO2000058284A1 (de) 1999-03-26 2000-03-17 Verfahren zur herstellung von n-acyl-3,4 - dehydroprolin und n-acyl-3,4 - dehydropiperidin-2-carbonsäure derivaten

Publications (1)

Publication Number Publication Date
AU3962500A true AU3962500A (en) 2000-10-16

Family

ID=7902464

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39625/00A Abandoned AU3962500A (en) 1999-03-26 2000-03-17 Method of producing 3,4-dihydroprolines and 3,4-dehydropiperidines

Country Status (22)

Country Link
US (1) US6579971B1 (enExample)
EP (1) EP1165509B1 (enExample)
JP (1) JP3868210B2 (enExample)
KR (1) KR20010104730A (enExample)
CN (1) CN1345310A (enExample)
AT (1) ATE278665T1 (enExample)
AU (1) AU3962500A (enExample)
BR (1) BR0009330A (enExample)
CA (1) CA2368479C (enExample)
CZ (1) CZ20013456A3 (enExample)
DE (2) DE19913699A1 (enExample)
ES (1) ES2230088T3 (enExample)
HK (1) HK1045156A1 (enExample)
HU (1) HUP0200420A2 (enExample)
IL (1) IL145525A0 (enExample)
MX (1) MXPA01009679A (enExample)
NO (1) NO20014645L (enExample)
RU (1) RU2001129097A (enExample)
TR (1) TR200102747T2 (enExample)
TW (1) TWI276626B (enExample)
WO (1) WO2000058284A1 (enExample)
ZA (1) ZA200107629B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100396666C (zh) * 2005-12-14 2008-06-25 郑州大学 (4s)-1-叔丁氧羰基-4-氨基-l-脯氨酸乙酯及其合成工艺

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291040A (en) * 1979-10-22 1981-09-22 E. R. Squibb & Sons, Inc. Mercaptoacyl derivatives of 4-disubstituted prolines and 4-substituted dehydroprolines
US5580575A (en) 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
JPH09502191A (ja) 1993-09-09 1997-03-04 シエーリング アクチエンゲゼルシヤフト 作用物質およびガスを含有する微粒子
DE19630082A1 (de) * 1996-07-26 1998-01-29 Basf Ag Verfahren zur Herstellung von 3-Pyrrolin-2-carbonsäure-Derivaten
US6090800A (en) 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
DE19723473A1 (de) * 1997-06-04 1998-12-10 Basf Ag Verfahren zur Herstellung von chiralen 3,4-Didehydroprolinen
CA2319433C (en) 1998-02-09 2008-04-22 Bracco Research S.A. Targeted delivery of biologically active media

Also Published As

Publication number Publication date
RU2001129097A (ru) 2004-03-20
CZ20013456A3 (cs) 2002-05-15
NO20014645D0 (no) 2001-09-25
MXPA01009679A (es) 2002-03-14
EP1165509B1 (de) 2004-10-06
KR20010104730A (ko) 2001-11-26
CA2368479C (en) 2005-03-01
WO2000058284A1 (de) 2000-10-05
TWI276626B (en) 2007-03-21
CN1345310A (zh) 2002-04-17
NO20014645L (no) 2001-09-25
HUP0200420A2 (hu) 2002-05-29
CA2368479A1 (en) 2000-10-05
ATE278665T1 (de) 2004-10-15
TR200102747T2 (tr) 2002-02-21
ES2230088T3 (es) 2005-05-01
BR0009330A (pt) 2002-01-08
IL145525A0 (en) 2002-06-30
ZA200107629B (en) 2002-09-17
DE50008117D1 (de) 2004-11-11
EP1165509A1 (de) 2002-01-02
JP2002540190A (ja) 2002-11-26
US6579971B1 (en) 2003-06-17
HK1045156A1 (zh) 2002-11-15
JP3868210B2 (ja) 2007-01-17
DE19913699A1 (de) 2000-09-28

Similar Documents

Publication Publication Date Title
TW197936B (enExample)
AU6350699A (en) Chemical compounds
AU8974298A (en) 1,4,7,10-tetraazabicyclo{8.2.2}tetradecan-2-one, a process for the preparation thereof and the use thereof for the preparation of tetraazamacrocycles
AU2383000A (en) Process for deactivation of polyolefin compositions utilizing carbon dioxide as a deactivation agent
EP0773081A4 (en) CHUCK FOR CUTTING TOOL
AU2308197A (en) Novel terphenyl compounds and medicines containing the same
AU3962500A (en) Method of producing 3,4-dihydroprolines and 3,4-dehydropiperidines
AU4304696A (en) Process for preparing aliphatic alpha,omega-aminonitriles
AU684327B2 (en) Bridged cyclopentadienylmagnesium compounds and process for the preparation thereof and use thereof for preparing metallocenes
CA2256620A1 (en) A process for preparing certain aza cyclohexapeptides
HU9301931D0 (en) Process for the production of azabicyclo [2.2.2] octane-3-imines and thereof inrtermediers
CA2256559A1 (en) N-bis- or n-tris-[(1,2-dicarboxy-ethoxy)-ethyl]-amine derivatives and preparation and use of the same
TW360658B (en) Novel water-soluble fluoroethylcamptothecin derivative and process for production thereof
AU6699600A (en) Formulations of fluorescent whitening agents
AU2002365378A1 (en) Process for preparing 3,3',6,6'-tetraalkyl-2,2'-biphenols and 3,3',6,6'-tetraalkyl-5,5'-dihalo-2,2'-biphenols
AU8631698A (en) A process for the preparation of tetraazamacrocycles
CA2231800A1 (en) Process for the preparation of 2,6-pyridinedicarboxylic acid esters
EP0900785A3 (en) Vitamin A related compounds and process for producing the same
WO2000002847A3 (en) A process for the preparation of 4-carboxy- 5,8,11- tris(carboxymethyl)- 1-phenyl- 2-oxa- 5,8,11- triazatridecan- 13-oic acid
MY122830A (en) Process for the preparation of (alpha)-(2-4-disulfophenyl)-n-tert-butylnitrone and pharmaceutically acceptable salts thereof
GB2333294A (en) Cytokine production inhibitors
IL97040A0 (en) Novel antibiotic,deoxymulundocandin,a process for its production and its use as medicament
CA2276310A1 (en) Process for the production of tetrazolylbenzopyrans
AU2307595A (en) A process for the preparation of 5,6-dihydroxy-2-amino- 1,2,3,4-tetrahydronaphthalene derivatives
HU9904315D0 (en) Process for preparing orthoesters

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted